Vita 34 - 股票

Vita 34 权益回报率 2024

Vita 34 权益回报率

-0.08

股票代码

V3V.DE

ISIN

DE000A0BL849

WKN

A0BL84

在2024年,Vita 34的股本回报率(ROE)为-0.08,较上一年的-1.64 ROE增长了-95.18%

Vita 34 Aktienanalyse

Vita 34在做什么?

Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.

权益回报率的详细信息

Vita 34的股本回报率(ROE)解密

Vita 34的股本回报率(ROE)是一项基本的指标,用于评估公司相对于自有资本的盈利能力。ROE通过将净利润除以股东的股权来计算,展示了公司从股东投资中获取收益的效率。较高的ROE代表着增加的效率和盈利能力。

年度比较

对Vita 34的ROE进行年度比较分析有助于追踪盈利趋势和财务表现。ROE的上升表明了盈利能力和为股东创造价值的增加,而ROE的下降则可能表明了盈利或者资本管理方面的问题。

对投资的影响

Vita 34的ROE对评估公司的盈利能力、效率和投资吸引力的投资者来说是至关重要的。强大的ROE显示出公司将股权投资转化为盈利的能力,从而增加了其对潜在和现有投资者的吸引力。

对ROE波动的解读

Vita 34的ROE的变化可能源于净利润、股权或两者的波动。这些波动被用来评估管理效率、财务策略及其相关的风险和机会,并帮助投资者做出明智的决策。

关于Vita 34股票的常见问题

Vita 34今年的股本回报率(ROE)有多高?

Vita 34今年的ROE为-0.08 undefined。

Vita 34的股权回报率(ROE)与去年相比有何变化?

与去年相比,Vita 34的ROE已经下降了-95.18%。

Vita 34的高ROE(股本回报率)对投资者有什么影响?

一个高ROE表明Vita 34获得了良好的资本回报,并成功地将其投资变现。对投资者来说,这是一个积极的指标。

Vita 34的投资者,低ROE(股权回报率)会有什么影响?

一个较低的ROE可能表明Vita 34在成功地将其投资变现方面面临困难,这可能对投资者来说是一个负面的信号。

Vita 34的权益回报率(ROE)变化会对公司产生什么影响?

ROE(股东权益回报率)的变动Vita 34可能是衡量公司财务表现的指标,并显示该公司与同行业其他公司相比有多成功。

如何计算Vita 34的ROE(股本回报率)?

ROE(股本回报率)的计算方法是将公司的利润除以总股本。公式为:ROE = 利润 / 总股本。

Vita 34的股本回报率(ROE)受哪些因素影响?

影响Vita 34的股权回报率(ROE)的一些因素包括资本利用效率,公司的盈利能力和融资结构等。

可以采取哪些战略措施来提高ROE(股本回报率)?

为了提高的股本回报率(ROE),可以采取诸如削减成本、提高销售额、提高使用股本的效率以及在融资结构中进行更改等措施。重要的是,公司需要对其财务状况进行深入审查,以确定最佳的战略措施以提高股本回报率(ROE)。

Vita 34支付多少股息?

在过去的12个月中,Vita 34支付了0.16 EUR 的股息。这相当于大约3.48 %的股息收益率。在未来的12个月内,Vita 34预计将支付0 EUR的股息。

Vita 34的股息收益率有多高?

Vita 34当前的股息收益率为3.48 %。

Vita 34什么时候支付股息?

Vita 34按季度支付股息。这些股息将在, , , 月份分发。

Vita 34的股息有多安全?

Vita 34 在过去0年里每年都支付了股息。

Vita 34的股息有多高?

预计未来12个月的股息将达到0 EUR。这相当于0 %的股息收益率。

Vita 34位于哪个行业?

Vita 34 被分配到“健康”板块。

Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?

要获得Vita 34在支付的0.16 EUR的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Vita 34最后一次支付股息是什么时候?

上一次股息发放日期为。

Vita 34在2023年的股息是多少?

在2023年,Vita 34 分配了0 EUR作为股息。

Vita 34 的股息是以哪种货币支付的?

Vita 34的股息将以EUR的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Vita 34 股票在以下供应商处可进行定投计划:Trade Republic

Andere Kennzahlen von Vita 34

我们对Vita 34 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Vita 34 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: